EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives

Hazim O Khalifa, Yousef M Al Ramahi

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25020739 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hazim O Khalifa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, United Arab Emirates University, Al Ain P.O. Box 1555, United Arab…. Hauptthemen laut MEDLINE: Cyclonic Storms, COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a new coronavirus in the Coronaviridae family. The COVID-19 pandemic, caused by SARS-CoV-2, has undoubtedly been the largest crisis of the twenty-first century, resulting in over 6.8 million deaths and 686 million confirmed cases, creating a global public health issue. Hundreds of notable articles have been published since the onset of this pandemic to justify the cause of viral spread, viable preventive measures, and future therapeutic approaches. As a result, this review was developed to provide a summary of the current anti-COVID-19 drugs, as well as their timeline, molecular mode of action, and efficacy. It also sheds light on potential future treatment options. Several medications, notably hydroxychloroquine and lopinavir/ritonavir, were initially claimed to be effective in the treatment of SARS-CoV-2 but eventually demonstrated inadequate activity, and the Food and Drug Administration (FDA) withdrew hydroxychloroquine. Clinical trials and investigations, on the other hand, have demonstrated the efficacy of remdesivir, convalescent plasma, and monoclonal antibodies, 6-Thioguanine, hepatitis C protease inhibitors, and molnupiravir. Other therapeutics, including inhaled medicines, flavonoids, and aptamers, could pave the way for the creation of novel anti-COVID-19 therapies. As future pandemics are unavoidable, this article urges immediate action and extensive research efforts to develop potent specialized anti-COVID-19 medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclonic StormsCOVID-19United StatesHumansHydroxychloroquinePandemicsSARS-CoV-2

Stichwörter der Autor:innen

COVID-19SARS-CoV-2anti-COVID-19anti-COVID-19 mechanism of actionmonoclonal antibodiesviral inhibitors

Substanzen

Hydroxychloroquine

Autor:innen und Institutionen

  • Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, United Arab Emirates University, Al Ain P.O. Box 1555, United Arab Emirates.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.

Förderung

  • United Arab Emirates University

Zitieren

APA

Khalifa, H. O., & Al Ramahi, Y. M. (2024). After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25020739

Vancouver

Khalifa HO, Al Ramahi YM. After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25020739

BibTeX
@article{Khalifa2024,
  author = {Khalifa, Hazim O and Al Ramahi, Yousef M},
  title = {After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25020739}
}
Kostenlos starten →